ADDITIONAL INFORMATION CONTINUED REMUNERATION OF DIRECTORS 2023 Salary/fees $ Bonus $ Super– annuation $ Share based payments $ Total $ Non–Executive Directors Patrick Davies 125,000 – – – 125,000 Dr Trevor Scott 75,000 – – – 75,000 Dianne Angus 67,720 – 7,280 – 75,000 Dr Jenny Harry 67,720 – 7,280 – 75,000 Joe Basile 60,124 – 2,376 – 62,500 395,564 – 16,935 – 412,499 Executive Directors Jon Pilcher 548,654 500,000 26,346 289,404 1,364,404 Total 944,219 500,000 43,280 289,404 1,776,903 2022 Salary/fees $ Bonus $ Super– annuation $ Share based payments $ Total $ Non–Executive Directors Patrick Davies 125,000 – – – 125,000 Dr Trevor Scott 75,000 – – – 75,000 Dianne Angus 68,028 – 6,972 – 75,000 Dr Jenny Harry 68,028 – 6,972 – 75,000 336,056 – 13,944 – 350,000 Executive Directors Jonathan Pilcher 396,403 – 24,430 125,505 546,338 Total 732,459 – 38,374 125,505 896,338 Loan Funded Shares Jon Pilcher has an interest in 1,500,000 Loan Funded Shares held by Neuren Trustee Limited. As detailed in Note 13 to the Financial Statements, the Loan Funded Shares are subject to vesting conditions and repayment of a loan amounting to $1.84 per share ($2,760,000) before they can be transferred to Jon. Neuren Pharmaceuticals Limited Annual Report 2023 54
RkJQdWJsaXNoZXIy MjE2NDg3